Metabolic detoxification determines species differences in coumarin-induced hepatotoxicity.
暂无分享,去创建一个
George P Daston | Lois D Lehman-McKeeman | G. Daston | L. Lehman-Mckeeman | J. Vassallo | Jeffrey D Vassallo | Sarah M Hicks | Sarah M. Hicks
[1] D. Lewis,et al. Studies on the mechanism of coumarin-induced toxicity in rat hepatocytes: comparison with dihydrocoumarin and other coumarin metabolites. , 1989, Toxicology and Applied Pharmacology.
[2] M. Lang,et al. Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse. , 1988, Biochemical pharmacology.
[3] O Pelkonen,et al. Polymorphisms of CYP2A6 and its practical consequences. , 2001, British journal of clinical pharmacology.
[4] D. Lewis,et al. Comparison of the hepatic effects of coumarin, 3,4-dimethylcoumarin, dihydrocoumarin and 6-methylcoumarin in the rat. , 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[5] F. Gonzalez,et al. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. , 1990, Biochemistry.
[6] B. Lake. Investigations into the mechanism of coumarin-induced hepatotoxicity in the rat. , 1984, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.
[7] A. M. Api,et al. Comparative metabolism and kinetics of coumarin in mice and rats. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[8] S. Born,et al. o-hydroxyphenylacetaldehyde is a hepatotoxic metabolite of coumarin. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[9] G. Bepler,et al. Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method. , 2001, Toxicology.
[10] J. Idle,et al. Comparison of a novel thin-layer chromatographic-fluorescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine. , 1992, Journal of chromatography.
[11] A. Yoshida,et al. Determination of genotypes of human aldehyde dehydrogenase ALDH2 locus. , 1983, American journal of human genetics.
[12] R. Lindberg,et al. Mouse steroid 15 alpha-hydroxylase gene family: identification of type II P-450(15)alpha as coumarin 7-hydroxylase. , 1989, Biochemistry.
[13] A. Parkinson,et al. Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. , 1992, Archives of biochemistry and biophysics.
[14] V. Vasiliou,et al. Aldehyde dehydrogenase gene superfamily: the 2002 update. , 2003, Chemico-biological interactions.
[15] J. Mohler,et al. An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin , 2005, Journal of Cancer Research and Clinical Oncology.
[16] D. Agarwal,et al. Liver alcohol dehydrogenase and aldehyde dehydrogenase in the Japanese: isozyme variation and its possible role in alcohol intoxication. , 1980, American journal of human genetics.
[17] S. Born,et al. Synthesis and reactivity of coumarin 3,4-epoxide. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[18] J. Idle,et al. A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. , 1997, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[19] M. Przybylski,et al. Coumarin mercapturic acid isolated from rat urine indicates metabolic formation of coumarin 3,4-epoxide. , 1991, Chemical research in toxicology.
[20] B. Lake,et al. Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[21] J. Stengård,et al. Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C‐oxidase , 1998, FEBS letters.
[22] M. Ingelman-Sundberg,et al. Characterisation and PCR‐based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population , 1999, FEBS letters.
[23] J. Lipsky,et al. Inhibition of recombinant human mitochondrial and cytosolic aldehyde dehydrogenases by two candidates for the active metabolites of disulfiram. , 1997, Biochemistry.
[24] H. Yamazaki,et al. Ethnic-related differences in coumarin 7-hydroxylation activities catalyzed by cytochrome P4502A6 in liver microsomes of Japanese and Caucasian populations. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.
[25] D. Egan,et al. The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. , 1990, Drug metabolism reviews.
[26] A. Cohen. Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man. , 1979, Food and cosmetics toxicology.
[27] M. Oscarson. Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[28] R. T. Williams,et al. The Metabolism of [3-14C]Coumarin , 1961 .
[29] S. Born,et al. Identification of the cytochromes P450 that catalyze coumarin 3,4-epoxidation and 3-hydroxylation. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[30] V. Vasiliou,et al. Polymorphisms of Human Aldehyde Dehydrogenases , 2000, Pharmacology.
[31] J. Idle,et al. Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6 , 1998, European Journal of Clinical Pharmacology.
[32] D. Agarwal,et al. Aldehyde Dehydrogenase Deficiency as Cause of Facial Flushing Reaction to Alcohol in Japanese , 1995, Alcohol health and research world.
[33] R. C. Longland,et al. Metabolism of Coumarin in Man , 1969, Nature.
[34] A. Hiratsuka,et al. 4-Hydroxy-2(E)-nonenal enantiomers: (S)-selective inactivation of glyceraldehyde-3-phosphate dehydrogenase and detoxification by rat glutathione S-transferase A4-4. , 2000, The Biochemical journal.
[35] L. Hazleton,et al. Toxicity of coumarin. , 1956, The Journal of pharmacology and experimental therapeutics.
[36] B. Green,et al. Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method. , 1999, Pharmacogenetics.
[37] J. Fry,et al. Species differences in the metabolism and hepatotoxicity of coumarin. , 1993, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.
[38] O Pelkonen,et al. A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. , 1995, American journal of human genetics.
[39] W B Jakoby,et al. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. , 1974, The Journal of biological chemistry.
[40] O Pelkonen,et al. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. , 1992, Pharmacogenetics.
[41] H. Ramsdell,et al. Mouse liver glutathione S-transferase isoenzyme activity toward aflatoxin B1-8,9-epoxide and benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide. , 1990, Toxicology and applied pharmacology.
[42] D. G. Walters,et al. Identification of o-hydroxyphenylacetaldehyde as a major metabolite of coumarin in rat hepatic microsomes. , 1992, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[43] J. Freudenstein,et al. Single copy of variant CYP2A6 alleles does not confer susceptibility to liver dysfunction in patients treated with coumarin. , 2003, International journal of clinical pharmacology and therapeutics.
[44] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[45] J. Fry,et al. O-hydroxyphenylacetaldehyde: a major novel metabolite of coumarin formed by rat, gerbil and human liver microsomes. , 1991, Biochemical and biophysical research communications.
[46] S. Born,et al. In vitro kinetics of coumarin 3,4-epoxidation: application to species differences in toxicity and carcinogenicity. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[47] M. Lang,et al. Cytochrome P4502A-mediated coumarin 7-hydroxylation and testosterone hydroxylation in mouse and rat lung. , 1993, Pharmacology & toxicology.
[48] B. Lake,et al. Comparison of the hepatotoxicity of coumarin in the rat, mouse, and Syrian hamster: a dose and time response study. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[49] D. Judah,et al. Metabolic basis of the species difference to aflatoxin B1 induced hepatotoxicity. , 1983, Biochemical and biophysical research communications.
[50] D. G. Walters,et al. Metabolism of coumarin and 7-ethoxycoumarin by rat, mouse, guinea pig, cynomolgus monkey and human precision-cut liver slices. , 1994, Xenobiotica; the fate of foreign compounds in biological systems.
[51] O. Pelkonen,et al. CYP2A6: a human coumarin 7-hydroxylase. , 2000, Toxicology.
[52] G. Daston,et al. Liquid chromatographic determination of the glutathione conjugate and ring-opened metabolites formed from coumarin epoxidation. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.